Similar articles

• Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.

  Snochowski M, Pousette A, Ekman P, Bression D, Andersson L, Högberg B, Gustafsson JA. Snochowski M, et al. J Clin Endocrinol Metab. 1977 Nov;45(5):920-30. doi: 10.1210/jcem-45-5-920. J Clin Endocrinol Metab. 1977. PMID: 72758 No abstract available.
• Androgen receptors in benign and malignant prostatic tissue.

  Lakey WH, Bruchovsky N, Callaway T, Comeau T, Lieskovsky G, Rennie P, Shnitka T, Wilkin P. Lakey WH, et al. Trans Am Assoc Genitourin Surg. 1979;71:19-22. Trans Am Assoc Genitourin Surg. 1979. PMID: 94714
• Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.

  Mobbs BG, Johnson IE, Connolly JG, Clark AF. Mobbs BG, et al. J Steroid Biochem. 1978 Apr;9(4):289-301. doi: 10.1016/0022-4731(78)90620-9. J Steroid Biochem. 1978. PMID: 77938 No abstract available.
• Sex steroid hormone receptors and human prostatic hyperplasia and carcinoma.

  Robel P. Robel P. Ann Clin Res. 1980 Oct;12(5):216-22. Ann Clin Res. 1980. PMID: 6165318 Review. No abstract available.
• Androgen receptor assays in advanced prostatic cancer.

  Buttyan R, Olsson CA. Buttyan R, et al. Urol Clin North Am. 1984 May;11(2):311-7. Urol Clin North Am. 1984. PMID: 6375068 Review.